Primary cutaneous aspergillosis at the site of cyanoacrylate skin adhesive in a neonate

Primary cutaneous aspergillosis is a rare but potentially life‐threatening disease. We present the case of a premature infant who developed primary cutaneous aspergillosis with Aspergillus niger at the site of a skin abrasion that had been treated with a purple‐colored cyanoacrylate product. The inf...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric dermatology 2018-07, Vol.35 (4), p.494-497
Main Authors: Kusari, Ayan, Sprague, Jessica, Eichenfield, Lawrence F., Matiz, Catalina, Barrio, Victoria R.
Format: Article
Language:English
Subjects:
Abrasion
Adhesives - adverse effects
Antifungal agents
Antifungal Agents - therapeutic use
Aspergillosis
Aspergillosis - diagnosis
Aspergillosis - etiology
Aspergillosis - therapy
Case reports
Cyanoacrylates - adverse effects
Debridement - methods
Dermatomycoses - diagnosis
Dermatomycoses - therapy
Fluconazole
Fungal infections
Humans
Infant, Newborn
Infant, Premature
infection
Intravenous administration
Male
Medical dressings
neonatal
Neonates
Newborn babies
Premature birth
Skin
Skin - microbiology
Skin - pathology
skin barrier
therapy
Voriconazole
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Primary cutaneous aspergillosis is a rare but potentially life‐threatening disease. We present the case of a premature infant who developed primary cutaneous aspergillosis with Aspergillus niger at the site of a skin abrasion that had been treated with a purple‐colored cyanoacrylate product. The infection was treated successfully with gentle debridement of the cyanoacrylate product, followed by intravenous voriconazole and topical fluconazole. To our knowledge, this is the first reported case of primary cutaneous aspergillosis occurring at the site of cyanoacrylate‐based skin adhesive.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.13528